La Trobe

Egfrviii promotes cell survival during endoplasmic reticulum stress through a reticulocalbin 1‐dependent mechanism

journal contribution
posted on 2025-11-07, 01:50 authored by J Gomez, Z Areeb, SF Stuart, HPT Nguyen, L Paradiso, A Zulkifli, S Madan, V Rajagopal, MK Montgomery, Hui GanHui Gan, Andrew ScottAndrew Scott, Jordan Jones, AH Kaye, AP Morokoff, RB Luwor
Reticulocalbin 1 (RCN1) is an endoplasmic reticulum (ER)‐residing protein, involved in promoting cell survival during pathophysiological conditions that lead to ER stress. However, the key upstream receptor tyrosine kinase that regulates RCN1 expression and its potential role in cell survival in the glioblastoma setting have not been determined. Here, we demonstrate that RCN1 expression significantly correlates with poor glioblastoma patient survival. We also demonstrate that glioblastoma cells with expression of EGFRvIII receptor also have high RCN1 expression. Over‐expression of wildtype EGFR also correlated with high RCN1 expression, suggesting that EGFR and EGFRvIII regulate RCN1 expression. Importantly, cells that expressed EGFRvIII and subsequently showed high RCN1 expression displayed greater cell viability under ER stress compared to EGFRvIII negative glioblastoma cells. Consistently, we also demonstrated that RCN1 knockdown reduced cell viability and exogenous introduction of RCN1 enhanced cell viability following induction of ER stress. Mechanistically, we demonstrate that the EGFRvIII‐RCN1‐driven increase in cell survival is due to the inactivation of the ER stress markers ATF4 and ATF6, maintained expression of the anti‐apoptotic protein Bcl‐2 and reduced activity of caspase 3/7. Our current findings identify that EGFRvIII regulates RCN1 expression and that this novel association promotes cell survival in glioblastoma cells during ER stress.<p></p>

Funding

R.B.L. is a recipient of the Victorian Cancer Agency Mid-Career Research Fellowship (MCRF15017).

Victorian Cancer Agency Mid-Career Research Fellowship | MCRF15017

History

Publication Date

2021-03-02

Journal

Cancers

Volume

13

Issue

6

Article Number

1198

Pagination

21p.

Publisher

Multidisciplinary Digital Publishing Institute (MDPI)

ISSN

2072-6694

Rights Statement

© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

Usage metrics

    Journal Articles

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC